← Back to Analyst Consensus 
ARCT Buy
Arcturus Therapeutics Holdings Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Sep 24, 2026 | Citigroup | upgrade | Neutral → Buy | — | 54% |
| Sep 24, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 2, 2026 | Freedom Broker | initiate | — → Buy | — | 59% |
| Mar 18, 2026 | B. Riley Securities | initiate | Neutral → Buy | — | 55% |
| Mar 5, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 4, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Mar 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jan 6, 2026 | Citigroup | maintain | Neutral → Neutral | $7 | 54% |
| Nov 13, 2025 | Citigroup | maintain | Neutral → Neutral | $9 | 54% |
| Nov 11, 2025 | Piper Sandler | maintain | Overweight → Overweight | $72 | 54% |
| Nov 11, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $9 | 44% |
| Oct 24, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $12 | 44% |
| Oct 23, 2025 | Citigroup | downgrade | Buy → Neutral | $12 | 54% |
| Oct 23, 2025 | Wells Fargo | maintain | Overweight → Overweight | $20 | 54% |
| Oct 23, 2025 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Oct 22, 2025 | BTIG | maintain | Buy → Buy | $23 | 52% |
| Oct 22, 2025 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Aug 22, 2025 | Leerink Partners | maintain | Outperform → Outperform | $54 | 51% |
| Aug 12, 2025 | Wells Fargo | maintain | Overweight → Overweight | $42 | 54% |
| Aug 12, 2025 | Citigroup | maintain | Buy → Buy | $49 | 54% |
| Jul 2, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $35 | 55% |
| May 28, 2025 | Scotiabank | initiate | — → Sector Outperform | $32 | 55% |
| May 14, 2025 | Wells Fargo | maintain | Overweight → Overweight | $45 | 54% |
| May 13, 2025 | Canaccord Genuity | maintain | Buy → Buy | $66 | 48% |
| Apr 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Mar 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $68 | 48% |
| Mar 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Mar 7, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Mar 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $50 | 54% |
| Mar 6, 2025 | Leerink Partners | maintain | Outperform → Outperform | $65 | 51% |
| Feb 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Feb 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Jan 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $63 | 44% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Dec 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Aug 12, 2024 | Leerink Partners | initiate | — → Outperform | $70 | 51% |
| Aug 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $63 | 44% |
| Aug 6, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jul 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| May 10, 2024 | Canaccord Genuity | maintain | Buy → Buy | $86 | 48% |
| Mar 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Mar 11, 2024 | Canaccord Genuity | maintain | Buy → Buy | $87 | 48% |
| Mar 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Mar 8, 2024 | Wells Fargo | maintain | Overweight → Overweight | $58 | 54% |
| Feb 8, 2024 | Citigroup | maintain | Buy → Buy | $48 | 54% |
| Dec 13, 2023 | Canaccord Genuity | initiate | — → Buy | $0 | 48% |
| Nov 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
Price Target Trend
Apr 23, 2026 Oct 25, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days